nanoparticles; drugs; in vivo evaluation; permeability; Caco-2 HT29-5M21; cell cultures and co-cultures
Abstract :
[en] Poorly water-soluble drugs such as nifedipine (NIF) (similar to 20 mu g/mL) offer challenging problems in drug formulation as poor solubility is generally associated with poor dissolution characteristics and thus with poor oral bioavailability (BCS class H drugs). In order to enhance these characteristics, formulation of NIF as nanocrystals was carried out. NIF nanoparticles (NP) were prepared using high-pressure homogenization (HPH). Solubility and dissolution characteristics have been reported in previous work to be significantly enhanced for NIF NP. Influence of NIF particle size on NIF permeation rate across intestinal cell models (Caco-2 and HT29-5M21 cultures and co-cultures) was investigated in order to complement these promising in vitro data. Apical to basolateral transfer studies were carried out across Caco-2 and HT29-5M21 cultures and co-cultures. Caco-2/HT29-5M21 co-cultures (seeding ratio 3: 1) were evaluated to better represent in vivo intestinal conditions. The influence of chitosan in the NIF NP formulation with regard to in vitro NIF permeation rate was also evaluated. These studies showed that NIF permeation rate across the different in vitro models evaluated can be significantly enhanced (approximate to 6-fold) by formulation of NIF as nanoparticles. No significant difference was observed either in the presence of chitosan in the formulation or between the three cell models evaluated. To complement these observations, preliminary in vivo pharmacokinetic evaluations in Sprague-Dawley rats, in the fed and fasted states, were also carried out for both un-milled NIF and NIF NP.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Hecq, Julien; Université Libre de Bruxelles - ULB
Nollevaux, Géraldine
Deleers, M.
Fanara, D.
Vranckx, H.
Peulen, Olivier ; Université de Liège - ULiège > Services généraux (Faculté de médecine) > Service administratif de la Faculté (Médecine)
Dandrifosse, Guy ; Université de Liège - ULiège > Services généraux (Faculté de médecine) > Relations académiques et scientifiques (Médecine)
Amighi, Karim; Université Libre de Bruxelles - ULB
Language :
English
Title :
Nifedipine nanocrystals: pharmacokinetic evaluation in the rat and permeability studies in Caco-2/HT29-5M21 (co)-cultures
Liversidge G.G., Cundy K.C. - Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. - Int. J. Pharm., 125, 91-97, 1995.
Müller R.H., Jacobs C., Kayser O. - Nanosuspensions as particulate drug formulations in therapy rationale for development and what we can expect for the future. - Adv. Drug. Del. Rev., 47, 3-19, 2001.
Keck C.M., Müller R.H. - Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. - Eur. J. Pharm. Biopharm., 62 (1), 3-16, 2006.
Hecq J., Deleers M., Fanara D., Vranckx H., Amighi K. - Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. - Int. J. Pharm., 299, 167-177, 2005.
Pinto M., Robine-Léon S., Appay M.D., Kedinger M., Triadou N., Dussaulx E., Lacroix B., Simon-Assmann P., Haffen K., Fogh J., Zweibaum A. - Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. - Biol. Cell., 47, 323-330, 1983.
Walter E., Janich S., Roessler B.J., Hilfinger J.M., Amidon G.L. - HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans. - J. Pharm. Sci., 85, 1070-1076, 1996.
Hilgendorf C., Spahn-Langguthg H., Regardh C.G., Lipka E., Amidon G.L., Langguth P. - Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. - J. Pharm. Sci., 89, 63-75, 2000.
Balimane P.V., Chong S. - Cell-culture-based models for intestinal permeability: a critique. - Drug Discov. Today, 10 (5), 335-343, 2005.
Nollevaux G., Devillé C., El Moualij B., Zorzi W., Deloyer P., Schneider Y.G., Peulen O., Dandrifosse G. - Development of a serum-free co-culture of human intestinal epithelium cell-lines (Caco-2/HT29-5M21). - BMC Cell Biol., 7 (1), 20, 2006.
Boulenc X., Bourrie M., Fabre I., Roque C., Joyeux H., Berger Y., Fabre G. - Regulation of cytochrome P450IA1 gene expression in a human intestinal cell line, Caco-2. - J. Pharmacol. Exp. Ther., 263 (3), 1471-1478, 1992.
Teraoka R., Otsuka M., Matsuda Y. - Evaluation of photostability of solid-state dimethyl 1,4-dihydro-2,6-dimethyl-4-(2-nitro-phenyl)-3, 5-pyridinedicarboxylate by using Fourier-transformed reflection-absorption infrared spectroscopy. - Int. J. Pharm., 184, 35-43, 1999,
Lesuffleur T., Porchet N., Aubert J.P., Swallow D., Gum J.R., Kim Y.S., Real F.X., Zweibaum A. - Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations. - J. Cell. Sci., 106, 771-783, 1993.
Schneider Y.J. - Optimisation of hybridoma cell growth and monoclonal antibody secretion in a chemically defined, serum- and protein-free culture medium. - J. Immunol. Methods, 116, 65-77, 1989.
Halleux C., Schneider Y.J. - Iron absorption by intestinal epithelial cells: 1. CaCo2 cells cultivated in serum-free medium, on polyethyleneterephthalate microporous membranes, as an in vitro model. - In vitro Cell. Dev. Biol., 27A, 293-302, 1991.
Yu H., Cook T.J., Sinko P.J. - Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages. - Pharm. Res., 14, 757-762, 1997.
Foglieni C., Meoni C., Davalli A.M. - Fluorescent dyes for cell viability: an application on prefixed conditions. - Histochem. Cell Biol., 115, 223-229, 2001.
Patki K.C., Von Moltke L.L., Greenblatt D.J. - In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5. - Drug Metab Dispos., 7, 938-944, 2003.
Schmiedlin-Ren P., Thummel K.E., Fisher J.M., Paine M.F., Lown K.S., Watkins P.B. - Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1 alpha, 25-dihydroxyvitamin D3. - Mol. Pharmacol., 5, 741-754, 1997.
Hu M., Li Y., Davitt C.M., Huang S-M., Thummel K., Penman B.W., Crespi C.L. - Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxydoreductase. - Pharm. Res., 16 (9), 1352-1359, 1999.
Engman H.A., Lennernas H., Taipalensuu J., Otter C., Leidvik B., Artursson P. - CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies. - J. Pharm. Sci., 90 (11), 1736-1751, 2001.
Thummel K.E., Brimer C., Yasuda K., Thottassery J., Senn T., Lin Y., Ishizuka H., Kharasch E., Schuetz J., Schuetz E. - Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3. - Mol. Pharmacol., 60 (6), 1399-1406, 2001.
Pfrunder A., Gutmann H., Beglinger C., Drewe J. - Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines. - J. Pharm. Pharmacol., 55 (1), 59-66, 2003.
Da Violante G., Zerrouk N., Richard I., Frendo J.L., Zhiri A., Li-Khuan R., Tricottet V., Provot G., Chaumeil J.C., Arnaud P. - Short term Caco-2/TC7 cell culture: comparison between conventional 21-d and a commercially available 3-d system. - Biol. Pharm. Bull., 27 (12), 1986-1992, 2004.
Chun Y.J., Park S., Yang S.A. - Activation of Fas receptor modulates cytochrome P450 3A4 expression in human colon carcinoma cells. - Toxicol. Lett., 146 (1), 75-81, 2003.
Pool-Zobel B.L., Selvaraju V., Sauer J., Kautenburger T., Kiefer J., Richter K.K., Soom M., Wolfl S. - Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics. - Carcinogenesis, 26 (6), 1064-1076, 2005.
Yoshioka M., Ohnishi N., Sone N., Egami S., Takara K., Yokoyama T., Kuroda K. - Studies on interactions between functional foods or dietary supplements and medicines. III. Effects of Ginkgo biloba leaf extract on the pharmacokinetics of nifedipine in rats - Biol. Pharm. Bull., 27 (12), 2042-2045, 2004.
Smart J.D. - The basics and underlying mechanisms of mucoadhesion. - Adv. Drug Deliv. Rev., 57 (11), 1556-1568, 2005.
Thanou M., Verhoef J.C., Junginger H.E. - Oral drug absorption enhancement by chitosan and its derivatives. - Adv. Drug Deliv. Rev., 52 (2), 117-126, 2001.
Reitberg D.P., Love S.J., Quercia G.T., Zinny M.A. - Effect of food on nifedipine pharmacokinetics. - Clin Pharmacol Ther., 42 (1), 72-75, 1987.
